Cytochalasin B, a fungal metabolite, has been shown to inhibit hexose transport in a variety of cellular types, including erythrocytes (Bloch, 1973) , leucocytes (Zigmond & Hirsch, 1972) , adipose-cell 'ghosts' (Czech et al., 1973), fibroblasts and liver cells (Kletzien et al., 1972) and HeLa cells (Mitzel & Wilson, 1972) . Studies of effects of cytochalasin B on hexose transport in the nervous system are limited to two studies. Cytochalasin B inhibits the uptake of 2-deo~y[~H]glucose by frog dorsal-ganglia cell bodies (Anderson et al., 1972) and the uptake of amines by peripheral adrenergic neurons under anaerobic conditions (Paton, 1974) , a process which is dependent on the provision and transport of glucose (Paton, 1972) .
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We have studied the effect of cytochalasin B on the kinetics of unidirectional influx of glucose into the isolated perfused dog brain. Details of the preparation were reported previously ; essentially the dog brain is perfused with arterial blood and all the venous blood can be collected through an outlet over the confluence of the sinuses. The two-pump oxygenator system (control and experimental; Gilboe et al., 1970) was used in all experiments. The isolated brain was perfused from the control oxygenator (blood glucose concentration 5-8m~) except for brief periods during which glucose influx was determined, when the brain was perfused from the experimental oxygenator which contained cytochalasin B at the desired concentration (dissolved in 1 ml of ethanol per litre of blood). The blood glucose concentration in the experimental oxygenator was varied between 2 and 5 0 m~ to study the influx of glucose over a range of concentrations. Unidirectional influx of glucose was determined by an indicator-dilution technique (Betz et ul., 1973) , which permits measurement of the extraction of ~-[6-%]-glucose relative to an intravascular marker, 22Na, during a single passage through the brain circulation. A mixture of ~-[6-~H]glucose and ZZNa was injected rapidly into the carotid artery. Venous blood samples (30) were collected at 1 s intervals, starting 3s after the injection, and 22Na and [6-3H]glucose radioactivities were measured by liquid-scintillation counting. Blood samples were taken at the end of each indicator dilution and analysed for glucose and oxygen. Blood flow rate was determined by measuring the volume of a 1 min collection of venous blood. The electroencephalogram was recorded intermittently during all experiments.
The rate of unidirectional influx of glucose, 0, was calculated from the following equation : Control influx of glucose was determined with the brain perfused from the control oxygenator. The brain was then perfused for 60-70s from the experimental oxygenator containing 30,u~-cytochalasin B and then returned to the control oxygenator and a further influx determined 4min later. FplW values were the same for both groups. NS, Not significant.
(,umol/min per ~)+s.E.M. (mllmin) and W the brain weight (g). Since the extraction varies with the plasma flow rate only values that were within the Fpl Wrange of 0.422-0.585 were included. The variations of glucose influx with increasing blood glucose concentrations were fitted to hyperbolae described by the Michaelis-Menten equation. Kinetic data from regression analysis of standard kinetic plots is shown in Table 1 . The inhibition is non-competitive. Replots of the slope or intercept against the inhibitor concentration were best fitted by parabolic functions, making it difficult to determine a meaningful K, value. The non-linearity of such plots may be due to any, or a combination, of the following factors. (1) The concentrations of inhibitor used in the plots are the concentrations added to the whole blood. The concentration of free cytochalasin in the plasma is probably lower than this because cytochalasin B is known to bind to a finite number of binding sites (3 x lo5 sites per cell) on the erythrocyte (Taverna & Langdon, 1973) . (2) There may be high-and low-affinity binding sites in the brain, as in the erythrocyte (Lin & Spudich, 1974) . Increasing the glucose concentration of the medium inhibited the high-affinity binding of cytochalasin to the erythrocyte, with halfmaximal inhibition at 5 0 m~. (3) There may be a co-operative binding effect.
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The approximate K, for the present study is about 2.5 x l O d S~, a value similar to that found to produce 50 % inhibition of deoxyglucose uptake in dorsal-ganglia cell bodies (Anderson et al., 1972) . Three brain preparations were used to test the reversibility of cytochalasin B inhibition. In each preparation the control influx of glucose was determined with the brain perfused from the control oxygenator. The brain was perfused for 60-70s from the experimental VOl. 4 oxygenator containing 30p~-cytochalasin Band returned to the control oxygenator, and a further influx of glucose determined 4min later. The glucose concentration in both oxygenators was the same. The results (Table 2) show that the inhibition is completely reversed within 4min of perfusing the brain with cytochalasin-free blood. The rapid reversibility of the inhibition is in agreement with studies of effects of cytochalasin B on hexose transport in other cell systems (Zigmond & Hirsch, 1972; Czech et al., 1973) .
